OCT is an England-based biopharmaceutical company that develops prescription cannabinoid medicines for the treatment of severe pain conditions.
Business Model:
Revenue: $0
Employees: 2-10
Address: 267 Banbury Road
City: Oxford
State: england
Zip: OX2 7HT
Country: GB
OCT is an England-based biopharmaceutical company that develops prescription cannabinoid medicines for the treatment of severe pain conditions.
Contact Phone:
Contact Email:
Listed Exchange:
OTCMKTS
IPO Date:
5/17/2021
Ticker Symbol:
OCTHF
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2018 | Series A | - | 6/2018 | Series A | 2 | $10M |
Casa Verde Capital Julien Codorniou Casa Verde Capital Julien Codorniou |
12/2021 | IPO | - | 6/2018 | Series A | - |
Casa Verde Capital Casa Verde Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|